Robert B. Den, MD, associate professor of radiation oncology, Thomas Jefferson University Hospital, discusses the future of prostate cancer research.
Robert B. Den, MD
Advertisement
Articles by Robert B. Den, MD
Robert B. Den, MD, associate professor of radiation oncology, Thomas Jefferson University Hospital, discusses bone metastases in prostate cancer.
Robert B. Den, MD, associate professor of radiation oncology, Thomas Jefferson University Hospital, discusses bone-targeting agents in prostate cancer.
Robert B. Den, MD, associate professor of Radiation Oncology, Jefferson Health, discusses the use of radiation therapy as a treatment for patients with prostate cancer.
Advertisement
Latest Updated Articles
Dr. Den on Radiation Therapy in Prostate CancerOctober 31st 2016
Dr. Den Discusses Bone-Targeting Agents in Prostate CancerMarch 20th 2018
Dr. Den Discusses Bone Metastases in Prostate CancerApril 4th 2018
Dr. Den Discusses the Future of Prostate Cancer ResearchApril 25th 2018
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient mHSPC
2
FDA Approves Adjuvant Belzutifan Plus Pembrolizumab in ccRCC
3
Luspatercept Misses Primary RBC-TI End Point But Shows Clinically Meaningful Improvement for Anemia in Myelofibrosis
4
CLL14 Final Analysis Shows Long-Term PFS Gain With Venetoclax/Obinutuzumab in Previously Untreated CLL
5